Clinical trial / 2015
Ginger powder supplementation for 12 weeks improved blood sugar, HbA1c, apolipoproteins, and malondialdehyde in type 2 diabetic patients.
In a randomized, double-blind, placebo-controlled clinical trial, 41 type 2 diabetic patients received either 2 g/day of ginger powder supplement or lactose placebo for 12 weeks. Compared to baseline and the control group, ginger supplementation significantly reduced levels of fasting blood sugar, hemoglobin A1c, apolipoprotein B, apolipoprotein B/apolipoprotein A-I, and malondialdehyde, while significantly increasing apolipoprotein A-I (p<0.05).
- Study type
- Randomized, double-blind, placebo-controlled clinical trial
- Who was studied
- 41 type 2 diabetic patients (22 in ginger group and 19 in control group)
- What was measured
- Fasting blood sugar, HbA1c, apolipoprotein B, apolipoprotein A-I, and malondialdehyde
THE PAPER
The effects of ginger on fasting blood sugar, hemoglobin a1c, apolipoprotein B, apolipoprotein a-I and malondialdehyde in type 2 diabetic patients.
Khandouzi N, Shidfar F, Rajab A, Rahideh T, Hosseini P, Mir Taheri M. Iran J Pharm Res, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.